Introduction {#Sec1}
============

Butyric acid is a saturated C4 fatty acid and intermediate in the clostridial biosynthesis of butanol. As such, an efficient means to produce it from glucose or other biomass-derived carbohydrates could enable efficient biofuels production from renewable biomass. In *Clostridium beijerinckii*, *n*-butanol production at yields of up to 74% of the theoretical maximum and at titers of up to 13 g/L has been reported (Ezeji et al. [@CR8]). In *Clostridium tyrobutyricum*, which ends its fermentation at butyrate and does not produce butanol, butyrate yields of 78% of the theoretical maximum and titers of up to 50 g/L have been reported (Liu et al. [@CR13]). Butyrate biosynthesis in clostridia is believed to proceed by the pathway shown in Fig. [1](#Fig1){ref-type="fig"}. Fig. 1Pathways of butyrate and butanol biosynthesis from acetyl-CoA (AcCoA) in *Clostridium acetobutylicum*. Also shown is the reaction for the non-clostridial *tesB* gene product (thioesterase II), which can hydrolyze acyl-CoAs directly to free carboxylic acids in a single step

Because clostridia are more difficult to transform, are sensitive to oxygen, exhibit complex fermentation kinetics, and can form spores, they can be difficult to engineer. Synthetic biology promises to simplify and expedite the design and engineering of metabolic pathways for the bioconversion of various feedstocks to desired fuels and chemicals. Several groups have recently applied synthetic biology approaches to the synthesis of *n*-butanol in a well-studied, robust host organism such as *Escherichia coli* (Atsumi et al. [@CR3]; Inui et al. [@CR11]; Nielsen et al. [@CR16]), but always at yields under 15% of the theoretical, and with titers less than 0.7 g/L. Two groups have assayed butanol pathway enzymes in cell extracts of heterologous hosts (Inui et al. [@CR11]; Nielsen et al. [@CR16]) and found that activity levels of the butanoyl-CoA dehydrogenase, encoded by *bcd* and accompanying electron transfer flavoproteins encoded by *etfA* and *etfB*, was either much lower than other pathway enzymes (Inui et al. [@CR11]) or not detectable in cell extracts (Nielsen et al. [@CR16]). However, despite the low or non-measureable activity of the *bcd-etfAB* encoded butanoyl-CoA dehydrogenase enzyme, *bcd* and *etfAB* are required for production of butanol in recombinant *E. coli*. Butanoyl-CoA dehydrogenase is known to be very oxygen sensitive and yet expression of *bcd* and *etfAB* under aerobic conditions led to measureable butanol production in *E. coli* (Atsumi et al. [@CR3]).

The *bcd-etfAB* encoded enzyme is thus a prime candidate as a bottleneck in the production of butanol from recombinant *E. coli* strains expressing the clostridial butanol biosynthesis genes, but bottlenecks may also occur in other reaction steps, and the role of oxygen is yet unclear. To bear further light on these questions, we measured acyl-CoA and related pool sizes in a battery of *E. coli* strains expressing clostridial genes for butyrate and butanol biosynthesis in a background strain engineered to favor butyrate production and to be an obligate aerobe.

Methods {#Sec2}
=======

Strains {#Sec3}
-------

*E. coli* K12 Δ*pta*, *E. coli* K12 Δ*ldhA*, and *E. coli* K12 Δ*adhE* were constructed via the method of Datsenko and Wanner ([@CR5]) starting from *E. coli* K12 MG1655. These genotypes were combined through a series of P1mediated transductions of the corresponding *pta*::*kan*, *ldhA*::*kan*, and *adhE*::*kan* alleles followed by elimination of the kanamycin marker with FLP-mediated recombination by pCP20. The resulting triple Δ*pta* Δ*ldhA* Δ*adhE* triple knockout was called the pal strain.

For expression of the lambda Red expressing electrocompetent cells, an IPTG-inducible variant of the pKD46 plasmid described by Wanner was used. The pal(DE3) derivative of pal was created with the DE3 lysogenization kit (Merck KGaA, Darmstadt, Germany) as per the manufacturer's directions.

The pal-1e strain was created by evolving *E. coli* pal pZE21-pab pHATet-CBEH (see below) in MOPS butyrate medium for 130 h after inoculation from an overnight 4 mL culture in LB broth. No noticeable growth occurred until after 110 h, when a population that could grow on butyrate as a sole carbon source. Colonies from this population were streaked from the exponentially growing culture in MOPS butyrate onto LB agar. Two colonies were picked from the resulting plates, grown overnight in LB broth, and re-inoculated into MOPS butyrate where they were found to exhibit a lag phase of less than 1 h. This strain may be a *fadR* deletion mutant (Campbell et al. [@CR4]) but has not been exhaustively characterized.

Plasmids {#Sec4}
--------

The ptb-buk operon was cloned from *Clostridium acetobutylicum* ATCC 824 genomic DNA using primers "MT ptb-buk Sense" (TCCC**CCCGGG**GGG AGTTTATAGGGCAAAAGTTTTATAAACATGGGTACTGG) and "MT ptb-buk Anti" (GG**GGTACC** CCGAGTGTACGACCAGTGATTAAGAGTTTTAA) endowed with XmaI and KpnI restriction sites (emphasized in primer sequences). This PCR product was digested and ligated to KpnI/XmaI digested pZE21-gfp(ASV) (Elowitz and Leibler [@CR7]) in order to create pZE21ptb-buk. The *atoB* gene was cloned from *E. coli* K12 MG1655 genomic DNA with primers "CF184 atoB Sense KpnI" (ACTCGGGTACCA TGAAAAATTGTGTCATCGTCAGTG) and "CF185 atoB anti HindIII" (AGAGGAAGCTT TTAATTCAACCGTTCAATCACCATC), digested with HindIII and KpnI, and ligated to the HindIII/KpnI fragment of pZE21-gfp(ASV) to create pZE21-atoB. The promoter-gene PLTetO1-atoB expression cassette from pZE21-atoB was amplified with primers "CF188 P(LTetO1) atoB Sense (AatII)" (GGCTTCCCAACCTTACCAGAGG) and "CF189 P(LTetO1) atoB Anti AatII(XbaI)" (CCTCGACGTCTAGATATTACCGCCTTTGAGTGAGCTG), and the resulting fragment was digested with AatII and ligated into an AatII-digested fragment of pZE21-ptb-buk in order to create pZE21-pab. pRK415-BCS (Nielsen et al. [@CR16]) was digested with SacI and AvrII, and the fragment containing the BCS operon with genes *crt*, *etfAB*, *bcd*, and *hbd* was ligated to XbaI-digested pHACm (Alper and Stephanopoulos [@CR2]) in order to create pHACm-CBEH. This plasmid carries genes for both tetracycline resistance (from pRK415-BCS) and chloramphenicol resistance (from pHACm). The CmR-conferring cat gene was disrupted in pHACm-CBEH by removing the 38 bp MscI and NcoI linker region and re-ligating the plasmid, in order to form pHATet-CBEH.

Culturing conditions {#Sec5}
--------------------

Batch oxygen-limiting cultures were maintained in 15 mL glass tubes (Bellco Glass, Inc.) stoppered with a butyl rubber septum. The septum was pierced with a 26-gauge or 27-gauge syringe needle. Antibiotics were used as required (Sambrook and Russell [@CR18]).

Anaerobically, *E. coli* requires bicarbonate for growth at low cell densities (Hornsten [@CR10]). In batch oxygen-limiting cultures without bicarbonate or CO~2~ supplementation, this requirement results in long lag phases as sufficient bicarbonate must be accumulated by the metabolism of inoculated cells before growth can begin. In continuous cultures, gas sparging can strip away bicarbonate as CO~2~, stopping growth. To avoid either possibility, MOPS minimal medium (Teknova Inc., Hollister, CA) was supplemented with 10 mM ammonium bicarbonate.

Stoichiometric modeling of the pal strain {#Sec6}
-----------------------------------------

We used a stoichiometric model of *E. coli* metabolism considered derived from the iJE660 model constructed by Jeremy Edwards and his co-workers (Edwards and Palsson [@CR6]). The model as originally formulated by Edwards et al. included redundant columns (fluxes) in an attempt to model stoichiometrically equivalent reactions. For example, the original model included five duplicate columns for the NADH-driven reduction of [L]{.smallcaps}-lactate to lactaldehyde (column indices were 109, 110, 111, 113, and 114). This model was simplified by removing 117 stoichiometrically duplicated fluxes, resulting in a stoichiometric matrix with dimensions 536 × 836. This simplified model was called "iJE660b." To construct stoichiometric product-growth envelopes, the growth yield was fixed at *μ*~f~ gDCW/mol glucose, and then fluxes to either succinate or butyrate were minimized and maximized subject to iJE660b and the additional growth = *μ*~f~ constraint. This procedure was repeated for many values of *μ*~f~ between zero and the maximum growth rate possible in iJE660b.

Determination of intracellular acyl-CoAs {#Sec7}
----------------------------------------

Our method for the determination of intracellular levels of short-chain acyl-CoA esters is derived from the method reported by Shimazu et al. ([@CR19]), but is modified in several aspects. Briefly, in a 1.5-mL Eppendorf tube, a 1-mL aliquot of exponential growth-phase bacterial culture was suspended above 400 μL of bromododecane, which itself was layered above 100 μL of metabolite extraction fluid. Because this cell harvesting method requires a dense, hexane- and bromododecane-immiscible polar, extraction fluid, we formulated an extraction fluid of acetonitrile, 2,2,2-trifluoroethanol, water, and trifluoroacetic acid in a 45:45:9:1 ratio (ρ ∼ 1.08 g/cm^3^). Samples were centrifuged for 30 s at 18,000×*g*. Cells were thus quickly centrifuged through the bromododecane layer into the metabolite extraction fluid, where they were rapidly lysed. Trials with GFP-expressing *E. coli* showed that cells pelleted in bromododecane alone retained fluorescence, but cell debris pelleted in extraction fluid had lost fluorescence after retrieval from the centrifuge. The culture medium and bromododecane supernatants were removed by aspiration, the crude extract was twice washed by the addition of 0.5 mL of hexanes (mixture of isomers) and subsequent vortexing and re-centrifugation. Of the original 100 μL, 70 μL of extract was transferred to a clean microcentrifuge tube in order to separate metabolite extracts from cell debris, and all samples were evaporated to dryness in a vacuum centrifuge (vaccufuge, Eppendorf AG, Hamburg, Germany) at 30 °C. Dried samples were stored indefinitely at −20 °C. This procedure avoids the use of both exotic extractants like Freon and trioctylamine (Shimazu et al. [@CR19]) as well as solid-phase extraction columns (Minkler et al. [@CR15]; Park et al. [@CR17]). Instead of post-column derivatization with bromoacetaldehyde and fluorescent detection of the resulting *1,N*^6^-ethenoadenine adduct, we used pre-column derivatization with 150 μL of 1 M chloroacetaldehyde in 150 mM sodium citrate buffer (pH = 4.0) and fluorescent detection.

We used two chromatographic methods: one which we called Method A was a simple modification of the protocol of Shimazu "Method 1" (Shimazu et al. [@CR19]), with identical HPLC setup but for a switch of Shimazu's buffer A with a 50% mixture of (100 mM sodium phosphate, 75 mM sodium acetate, pH 4.5) and 50% 60 mM magnesium chloride, with both buffers amended by addition of 1% *v*/*v* unstabilized tetrahydrofuran. The addition of magnesium chloride was necessary for chromatographic resolution of AcCoA and 3HB-CoA, which co-elute in the method originally reported by Shimazu and co-workers. As such, data reported by Shimazu for AcCoA pool sizes in *E. coli* and *Mixococcus xanthus* may be overestimates, due to conflation of 3HB-CoA and AcCoA pool sizes. Method A was used for all analyses of Strain Set I.

In a second method we called Method B, buffer A was 5 mM ammonium phosphate/1% *v*/*v* THF adjusted to pH 6.5 with phosphoric acid, and buffer B was 99:1 methanol/THF. The column temperature was 60 °C and flow rate was 1.2 mL/min and the gradient regime was: 0% B for 2 min, then from 0% B to 6.25% B by 3 min, from 6.25% B to 14.6% B by 7.5 min, from 14.6% B to 75% B by 13.3 min; a constant flow of 75% B until 15.3 min, to 0% B by 16 min; and a constant flow of 0% B for 2 min. We found this method is preferred for measurement of adenosine phosphates and free CoASH. For all samples analyzed with this method, hexanoyl-CoA was used as an internal standard by 1,000 × dilution of a 10-mM stock of hexanoyl-CoA (Sigma-Aldrich, St. Louis, MO) dissolved in PBS into metabolite extraction fluid, immediately before beginning the extractions. The peak areas of all analytes were normalized to the HexCoA peak size, and the normalized peak area was calibrated against known standards in order to quantify metabolite pool sizes. Method B was used for all analyses of Strain Set II and III.

The concentrations of acyl-CoAs were calculated from linear (*R*^2^ \> 0.9) standard curves obtained from stock solutions (AcCoA, ATP, ADP, AMP, and CoASH) or from spiking known amounts of acyl-CoA into wild-type *E. coli* K12 metabolite extracts (all other acyl-CoAs). The uncertainty in measured pool sizes was the root-mean-square of the standard error between duplicate or triplicate measurements and the standard error associated with the linear regression. This latter error term was dominant for low pool size measurements (\<100 pmol/(A600·mL).

Calculation of Δ~IPTG~Δ*G*′ {#Sec8}
---------------------------

The strains used in this study express butyrate or butanol biosynthesis genes from IPTG-inducible promoters. If the induction of gene expression with IPTG changes the pool sizes of pathway metabolites, the free energy change associated with any given pathway step will also change. The difference between the induced state of the pathway and uninduced state of the pathway is shown in Eq. [1](#Equ1){ref-type=""}, where *Q* indicates the measured, possibly non-equilibrated reaction quotient $\documentclass[12pt]{minimal}
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Results {#Sec9}
=======

Design of the pal strain and a stoichiometric driving force for butyrate production {#Sec10}
-----------------------------------------------------------------------------------

In order to balance reducing equivalents, the native metabolism of *E. coli* ferments glucose to produce acetate, ethanol, and lactate, all of which could conceivably compete with butyrate production. To test the effects of removing these pathways on stoichiometrically possible space for butyrate production, the genes *pta*, *adhE*, and *ldhA*, responsible for the fermentative production of acetate, ethanol, and lactate, respectively, were deleted from the constraint-based stoichiometric model of *E. coli* metabolism (Edwards and Palsson [@CR6]). In stoichiometric models *not* including clostridial butyrate biosynthesis reactions, these deletions led to a stoichiometric correlation between biomass formation and succinate production, as shown in Fig. [2a](#Fig2){ref-type="fig"}. In the Δ*pta*, Δ*adhE*, and Δ*ldhA* strain model (hereafter, the pal strain/model), growth without any succinate production was possible only up to biomass yields on glucose of 0.003 gDCW/1 mmol glucose, or about 0.017 gDCW/g glucose. This is about ten times lower than usual anaerobic biomass yields on glucose for *E. coli* (Hempfling and Mainzer [@CR9]). Introduction of the clostridial butyrate biosynthesis pathway reactions shown in Fig. [1](#Fig1){ref-type="fig"} into the stoichiometric model of *E. coli pal* metabolism caused a shift in the growth-optimal outlet for reducing equivalents, as shown in Fig. [2b](#Fig2){ref-type="fig"}. When the butyrate pathway was made available, growth yields exceed 0.094 gDCW/g glucose at a butyrate yield on glucose of only 0.1 mol/mol. The maximum biomass yield of the *pal* triple knockout model was the same as the (butyrate-producing) wild-type strain model, 0.032 gDCW/mmol glucose, and it occurred at a butyrate yield of 7.5 mol butyrate/10 mol glucose. Fig. 2Stoichiometrically feasible region for the anaerobic biosynthesis of **a** succinate and *E. coli* cell biomass from glucose and carbon dioxide and **b** butyric acid and *E. coli* cell biomass from glucose as the sole carbon source. Panel **c** shows the data in **b** from an alternate visual perspective for clarity

Thus, although the *E. coli* metabolic network has alternate routes for clearing glycolysis-generated reducing equivalents under anaerobic conditions (e.g., the production of succinate), introduction of butyrate production provides a more facile route for anaerobic biomass production, at least stoichiometrically. To ensure that the activity of clostridial butyrate biosynthesis enzymes expressed in *E. coli* was not obscured or outcompeted by native *E. coli* metabolism, the *pal* strain background was used for all measurements of the pool sizes of butyrate pathway intermediates. An unexpected property of the *pal* strain was obligate aerobicity (see Supplemental Information), which allowed for growth under strict oxygen limitation, where the rate of oxygen to supply to the culture limits the rate of growth, a similar to condition previously shown to improve performance of the butanol fermentations (Atsumi et al. [@CR3]).

Assessment of butyrate pathway activity by CoA pool size measurements in three strain sets {#Sec11}
------------------------------------------------------------------------------------------

To examine the factors that control performance of the clostridial butyrate biosynthesis pathway in the *E. coli* pal strain, we measured in three strain sets the pool sizes of the pathway intermediates coenzyme A (CoASH), acetyl-CoA (AcCoA), acetoacetyl-CoA (AcAcCoA), 3-hydroxybutyryl-CoA (3HB-CoA), crotonyl-CoA (CrtCoA), and butyryl-CoA (ButCoA). None of the strain sets produced measurable quantities of butyric acid, but proved to differ markedly in the pool sizes of various pathway intermediates. Strain Set I includes strains expressing clostridial butyrate biosynthesis genes from low- or medium-copy pSC101 and pZE-derived plasmids and medium strength P~LTetO1~-derived promoters. No strains in Strain Set I produced measureable quantities of butyric acid during growth on minimal glucose medium. In all of these strains (\#1--\#9 in Table [1](#Tab1){ref-type="table"}), AcCoA was the sole short-chain acyl-CoA detected from growth-phase cultures. The levels of AcCoA were similar in all of the strains, ranging from between 700 and 1,800 pmol/(A~600~·mL) for strains \#1--\#5. Strain \#1, containing all genes in the clostridial butyrate biosynthesis pathway (Fig. [1](#Fig1){ref-type="fig"}), did not have significantly different AcCoA pool sizes than strains \#2--\#5, "dropout" strains missing one or more pathway genes. Pool sizes were generally lower in strains \#6--\#9, which were identical to strains \#1--\#4 except for introduction of a pRARE plasmid which facilitates the translation of genes containing rare codons. Quantitative data are given in Supplemental Table S[4](#MOESM1){ref-type=""}. Table 1Strains and plasmids used in this studySource strainsDescriptionReference or Source*E. coli* K12 MG1655Wild-typeATCC 47076*pal*K12 Δ*pta* Δ*ldhA* Δ*adhE*This workTGD(cat + PHB)K12 with chromosomally inserted PHB biosynthesis pathway(Tyo et al. [@CR21])PlasmidspKD46temperature-sensitive, low-copy AmpR plasmid for chromosomal modification(Datsenko and Wanner [@CR5])pCP20temperature sensitive, AmpR expression module for the FRT recombinase(Datsenko and Wanner [@CR5])pJM12derivative of pKD46 with PBAD promoter replaced by PlacThis workpRK415-BCSsource of cloned clostridial CBEH operon(Nielsen et al. [@CR16])pZE21-gfp(ASV)medium-copy kanR plasmid with constitutive P(LTetO1) promoter(Elowitz and Leibler [@CR7]; Lutz and Bujard [@CR14])pZE21-ptb-bukpZE21 with gfp replaced by the ptb/buk polycistron from C. acetobutylicumThis workpZE21-pabInserts a P(LTetO1)-atoB expression cassette into pZE21-ptb-bukThis workpHACm-CBEHlow-copy SC101 derivative for the aTc-inducible expression of the CBEH operon from *C. acetobutylicum*This workpHATet-CBEHvariant of pHACm-CBEH with chloramphenicol marker removedThis workpRAREp15a-derived, CmR plasmid expressing tRNAs for rare codons in *E. coli*NovagenpHACm-Ølow-copy SC101 derivative without any expression cassette(Alper and Stephanopoulos [@CR2])pETDuet1-thi1-hbdMedium-copy T7 expression vector for clostridial ketothiolase *thi*1 and *S*-specific ketoacid reductase *hbd*(Tseng et al. [@CR20])pETDuet1-thi1-phaBReplaces *S*-3HB-CoA specific *hbd* in pETDuet1-thi1-hbd with *R*-3HB-CoA specific *phaB*(Tseng et al. [@CR20])pCDFDuet1-ptb-bukMedium-copy T7 expression vector for clostridial energy-conserving acyl-CoA phosphatase *ptb* and acyl phosphate kinase *buk*(Tseng et al. [@CR20])pCDFDuet1-tesBReplaces *ptb-buk* operon in pCDFDuet1-ptb-buk with *tesB* thioesterase(Tseng et al. [@CR20])pETDuet1-atoB, pETDuet1-atoB-gapAMedium-copy T7 expression vector for native *E. coli* ketothiolase *atoB* (and NADH-regenerating enzyme *gapA*)(Nielsen et al. [@CR16])pCDF-hbd-crtMedium-copy T7 expression vector for clostridial ketoacid reductase *hbd* and crotonase *crt*(Nielsen et al. [@CR16])pCOLA-bcd-etfABMedium-copy T7 expression vector for clostridial butyryl-CoA reductase *bcd* and accessory electron transfer flavoprotein genes *etfAB*(Nielsen et al. [@CR16])pACYC-adhE2Medium-copy T7 expression vector for clostridial alcohol dehydrogenase *adhE*2(Nielsen et al. [@CR16])pETDuet1-bktB-acdMedium-copy T7 expression vector for alternate ketothiolase *bktB* and acyl-CoA dehydrogenase *acd*(Nielsen et al. [@CR16])Strain Set I 1*pal* pZE21-pab pHATet-CBEHThis work 1e*strain 1 evolved to grow on butyrate as a sole carbon source*This work 2*pal* pZE21-ptb/buk pHATet-CBEHThis work 3*pal* pZE21-atoB pHATet-CBEHThis work 4*pal* pZE21-pab pHACm-ØThis work 5*pal* pZE21-gfp pHACm-ØThis work 6*pal* pZE21-pab pHATet-CBEH pRAREThis work 7*pal* pZE21-ptb/buk pHATet-CBEH pRAREThis work 8*pal* pZE21-atoB pHATet-CBEH pRAREThis work 9*pal* pZE21-pab pHACm-Ø pRAREThis workStrain Set II 11*pal*(*DE3*) pETDuet1-thi1-hbd pCDFDuet1-tesBThis work 12*pal*(*DE3*) pETDuet1-thi1-hbd pCDFDuet1-ptb-bukThis work 13*pal*(*DE3*) pETDuet1-thi1-phaB pCDFDuet1-tesBThis work 14*pal*(*DE3*) pETDuet1-thi1-phaB pCDFDuet1-ptb-bukThis work 911Strain \#11 transformed with pHATet-CBEHThis work 912Strain \#12 transformed with pHATet-CBEHThis work 914Strain \#14 transformed with pHATet-CBEHThis workStrain Set III 21*pal*(DE3) pETDuet1-atoB pCDF-hbd-crt pCOLA-bcd-etfAB pACYC-adhE2This work 22*pal*(DE3) pETDuet1-atoB-gapA pCDF-hbd-crt pCOLA-bcd-etfAB pACYC-adhE2This work 23*pal*(DE3) pETDuet1-bktB-acd pCDF-hbd-crt pCOLA-bcd-etfAB pACYC-adhE2This work

A strain of *E. coli* with the entire *Ralstonia eutropha*-derived pathway for polyhydroxybutyrate biosynthesis chromosomally integrated contains an alternate route for the synthesis of 3-hydroxybutyryl-CoA by use of the *R. eutropha* gene *phaB*. In contrast to the results with Strain Set I, a clone of this strain transformed with pHATet-CBEH and pZE21-pab (the same butyrate-producing plasmids used in Strain Set I), 3HB-CoA was detectable in cell extracts (Supplemental Table S[4](#MOESM1){ref-type=""}). This result suggested that either the expression level of *hbd* in Strain Set \#1 was insufficient for production of the first two pathway intermediates AcAcCoA and 3HB-CoA, or that availability of the redox cofactor NADH was limiting the activity of the *hbd*-encoded enzyme. In the first case, the bottleneck could be alleviated by increasing the expression of *hbd*, and in the second, the bottleneck might be eliminated by swapping NADH-requiring *hbd* for NADPH-requiring 3-hydroxybutyryl-CoA reductases, such as *phaB*.

Further pool size measurements were made on Strain Set II, which express *hbd* and other genes for the production of 3-hydroxybutyric acid from monocistronic operons driven by much stronger IPTG-inducible, T7-derived promoters (Tseng et al. [@CR20]). Measurements of intracellular acyl-CoAs in induced cultures of strains from Strain Set II revealed detectable quantities of 3HB-CoA, showing that expression levels of *hbd* in Strain Set I had been insufficient for measureable intracellular conversion of AcCoA to 3HB-CoA, and that intracellular NADH levels were sufficient for production of 3HB-CoA.

To test the effect of alleviating this bottleneck on the performance of the entire clostridial butanol biosynthesis pathways, pool sizes in a third set of strains was analyzed. This strain set bears plasmids containing the complete clostridial pathway for butanol fermentation (Nielsen et al. [@CR16]), and these plasmids have previously been used to produce small amounts (\<600 mg/L) of butanol. In this third strain set, butyryl-CoA was not reliably detected in IPTG-induced cultures (Table [2](#Tab2){ref-type="table"}). In contrast, slight amounts of butyryl-CoA were detected in non-induced strains, but the uncertainty in the level of butyryl-CoA detected under non-inducing conditions was still quite large. Butyryl-CoA levels were too low to be reliably detected in these extracts, as illustrated by the uncertainties given in Table [2](#Tab2){ref-type="table"} for ButCoA. Table 2Intracellular pool sizes in pmol/(A600·mL of free coenzyme A, acyl-CoAs, and adenosine phosphates in *E. coli* strains expressing clostridial butanol biosynthesis genesStrainCoASHAcCoAAcCoA/CoASH ratio3HB-CoAButCoAATPADPAMPECNO IPTG11676 ± 411,170 ± 461.7 ± 0.1318 ± 58 ± 4347 ± 37214 ± 31179 ± 580.61 ± 0.05112278 ± 131,059 ± 453.8 ± 0.2427 ± 619 ± 4220 ± 46150 ± 10105 ± 290.62 ± 0.03913477 ± 231,116 ± 2002.3 ± 0.4396 ± 4916 ± 1478 ± 61184 ± 2971 ± 150.78 ± 0.02214412 ± 771,216 ± 1233.0 ± 0.6314 ± 810 ± 4379 ± 105195 ± 27113 ± 290.69 ± 0.03321391 ± 220627 ± 1091.6 ± 0.94120 ± 5416 ± 2250 ± 68148 ± 3278 ± 50.68 ± 0.02622635 ± 26943 ± 1971.5 ± 0.32109 ± 1013 ± 4583 ± 305228 ± 6376 ± 170.79 ± 0.03223262 ± 148503 ± 691.9 ± 1.1225 ± 2516 ± 2164 ± 2114 ± 13104 ± 370.58 ± 0.058pal w.t.570 ± 2011,031 ± 2541.8 ± 0.7862 ± 4113 ± 8441 ± 197181 ± 56131 ± 610.71 ± 0.065+ IPTG11342 ± 421,218 ± 963.6 ± 0.526 ± 420 ± 205 ± 14 ± 131 ± 200.17 ± 0.02812528 ± 511,305 ± 1112.5 ± 0.31210 ± 94n.d.450 ± 188159 ± 21144 ± 790.70 ± 0.08813818 ± 80861 ± 3091.1 ± 0.39170 ± 17316 ± 2n.d.n.d.247 ± 1040.00 ± 0.000141,442 ± 5391,564 ± 3161.1 ± 0.46763 ± 87225 ± 20910 ± 504289 ± 80331 ± 1700.69 ± 0.06621981 ± 1,105665 ± 2310.7 ± 0.80322 ± 29035 ± 9542 ± 29578 ± 34211 ± 270.70 ± 0.05422364 ± 30676 ± 2821.9 ± 0.7933 ± 69 ± 6218 ± 22994 ± 5260 ± 270.71 ± 0.057231,244 ± 1,404788 ± 2160.6 ± 0.74407 ± 81332 ± 8611 ± 15126 ± 29235 ± 1670.69 ± 0.138pal w.t.298 ± 2101,134 ± 5593.8 ± 3.2787 ± 11613 ± 17337 ± 301177 ± 109187 ± 1740.61 ± 0.113Uncertainties shown are the root-mean-square of the standard error in the mean calculated from either two or three duplicate measurements and the standard error stemming from linear regression against HPLC calibration curves.

Our HPLC technique also allows determination of intracellular ATP, ADP, and AMP. From these universal energy metabolites, the adenylate energy charge (EC), a ratio of the ATP pool plus one half the ADP pool to total adenine phosphate pool, can be calculated. This ratio is an indicator of the energetic state of the cell. AMP and ADP pool sizes measured in Strain Sets II and III are generally consistent with previously obtained measurements (Shimazu et al. [@CR19]). The extremely low values for EC obtained in strains \#11 and \#13 after IPTG induction reflect the activity of the *tesB* gene product: the TesB enzyme does not regenerate ATP during the hydrolysis of 3HB-CoA to form free 3-hydroxybutyric acid; whereas with Ptb and Buk, ATP is regenerated during the two-step formation of 3-hydroxybutyric acid from 3HB-CoA. Pathway intermediates AcAcCoA and CrtCoA were not detected in any of the strain sets we studied.

A thermodynamic framework for relating pool size measurements to pathway activity {#Sec12}
---------------------------------------------------------------------------------

Enzymes accelerate the rate at which biochemical reactions reach equilibrium. The addition of IPTG leads to high-level overexpression of pathway enzymes, and thus should tend to push pathway reactions towards equilibrium. This push can be quantified using pool size measurements, if reaction thermodynamic data and pool size measurements are available. Because AcAcCoA and CrtCoA were not detectable in any of the strain sets we studied, we lumped the butyrate biosynthesis pathway into two reactions, the first being synthesis of 3HB-CoA from AcCoA and the second being the synthesis of ButCoA from 3HB-CoA.

Using the pool sizes in Table [2](#Tab2){ref-type="table"} and relevant thermodynamic parameters from the literature (see Supplemental Information), we estimated the effect of IPTG on equilibration of pathway reactions by computing Δ~IPTG~ΔG′ (see the "[Methods](#Sec2){ref-type="sec"}" section), as shown in Fig. [3](#Fig3){ref-type="fig"}. This figure shows that IPTG increased (made less thermodynamically favorable) the ΔG′ for conversion of AcCoA to 3HB-CoA for two of the 3HB-producing strains (strain \#12 and \#14), as shown by the positive values for Δ~IPTG~ΔG′. The Δ~IPTG~ΔG′ value for the 3HB-CoA-from-AcCoA reactions for strain \#13 was also likely positive, but a value of 0 cannot be excluded because of the slight overlap of the error bar and the Δ~IPTG~ΔG′ = 0 center axis. In strain \#11, measurements did not reliably detect intracellular 3HB-CoA, increasing the uncertainty in Δ~IPTG~ΔG′ values. Fig. 3The change from adding IPTG inducer in measured ΔG′ values for component reactions of the clostridial butyrate or butanol biosynthesis pathway. A positive Δ~IPTG~ΔG′ indicates that induction of pathway genes has filled pool sizes for reaction products (or depleted pool sizes for reactants) of the given reaction, and as such, represents evidence that pathway induction leads to conversion of thermodynamic chemical potential into flux through the given reaction. The graph shows Δ~IPTG~ΔG′ for nine strains numbered according to Table [1](#Tab1){ref-type="table"}. For some strains, induction clearly shifts the 3HB-CoA synthesis reaction (left panel) toward equilibrium. In contrast, no such change is shown for the ButCoA synthesis reaction (right panel), indicating that this pathway step is likely rate-limiting

The failure to detect appreciable levels of butyryl-CoA in Strain Set II and III under either inducing or non-inducing conditions made accurate estimation of Δ~IPTG~ΔG′ fraught with uncertainty. However, it is notable that the estimated ranges for Δ~IPTG~ΔG′ shown for the 3HB-CoA → ButCoA set of pathway reactions all overlap 0. The parent pal strain, with no plasmids or pathway genes, also had estimated Δ~IPTG~ΔG′ values near 0 kJ/mol, as would be expected for a strain with no pathway activity of any type.

Unexpected behavior of *ptb* and *buk* {#Sec13}
--------------------------------------

Strain \#12 (in the *pal* background) expressing both *hbd* and *ptb-buk* also produced much higher amounts of crotonic acid in the medium supernatant than control strains. Figure [4](#Fig4){ref-type="fig"} shows crotonate production for several strains growing under various conditions in MOPS minimal media. Strain \#1, expressing all the genes of the clostridial butyrate biosynthesis pathway at relatively low levels, produced 76 μM crotonic acid during growth on MOPS glucose medium. In MOPS butyrate medium, this strain did not show signs of growth until more than 110 h of culture, after which growth eventually began. Two colonies isolated by streaking onto LB agar after growth in MOPS butyrate showed no lag phase on reinoculation into MOPS butyrate. This mutant evolved from Strain \#1, called Strain \#1e, produced 10× more crotonate than its parent in growth on MOPS glucose. Crotonic acid production was much lower in Strain \#1e growing on MOPS butyrate, where flux through butyrate biosynthetic reactions (Fig. [1](#Fig1){ref-type="fig"}) is reversed. Fig. 4Unexpected activity of the clostridial *ptb-buk* operons (encoding phosphotransbutyrylase and butyrate kinase) in recombinant *E. coli*. Crotonic acid is a byproduct of co-expressing both *hbd* (*S*-3-hydroxybutyryl-CoA dehydrogenase) and *ptb-buk*. The expression of butyrate biosynthesis genes (crotonase, *crt*; *hbd*; *ptb-buk*; or the *R*-3-hydroxybutyryl-CoA dehydrogenase-encoding *phaB* gene) is shown semi-quantitatively by color. Red indicates omission of a gene, shades of green indicate semiquantitative expression level. Crotonate production does not depend on the presence of *crt*, correlates with the expression level of *hbd*, and is much higher when growing on glucose than when growing on butyrate. Strain numbers refer to Table [1](#Tab1){ref-type="table"}

Strain \#12 gave 3× more crotonic acid than strain \#1. These strains differ in two important ways: (a) *hbd* is expressed using the high-copy pETDuet1-*thi1*-*hbd* plasmid and the strong T7 promoter and (b) *crt* and thus the crotonase enzyme is not present in strain 12. Thus, the production of crotonate does not depend on the crotonase enzyme or the *crt* gene. Also, crotonate was produced at much, much lower levels in strains expressing *tesB* in place of *ptb-buk* such as 911, 11, or 13, illustrating that crotonate production depends on expression of both *hbd* and *ptb-buk*, but not *crt*. Strains expressing *phaB* in place of *or in addition* to *hbd* also showed very low or indetectable crotonate production. This may be related to the difference in stereochemistry of the 3-hydroxybutyryl-CoA that results from PhaB versus Hbd. That is, dehydration of 3-hydroxybutyryl-CoA to crotonyl-CoA may require the *S-*enantiomer produced by Hbd. While the inclusion of *phaB* in addition to *hbd* should enable the production of both enantiomers, differences in pathway activity could account for the greatly reduced crotonate production in the presence of *phaB*. Thus, these conditions seemed necessary and sufficient for crotonate production of over 100 μM: (a) co-expression of the *hbd* and *ptb-buk* operons, (b) the absence of alternative pathway genes including *tesB* and *phaB*, (c) operation of the butyrate pathway in the forward direction as in growth on glucose. The expression of the *crt* gene was unrelated to crotonate production.

The results shown in Fig. [4](#Fig4){ref-type="fig"} suggest that *E. coli* strains expressing both *hbd* and *ptb-buk* produce crotonate as a minor fermentation product. Crotonate production may involve a side reaction of the *ptb-buk* system whereby *S*-3HB-CoA, *S*-3-hydroxybutyryl phosphate, or *S*-3-hydroxybutyric acid is converted to crotonate; however, background activities present on the *E. coli* genome may also be involved. We also observed 3HB production in *E. coli* pal(DE3) strains expressing both *hbd* and *ptb-buk*, but the level of production was not reproducible and varied in duplicate experiments between background levels and those previously measured (Tseng et al. [@CR20]) for *E. coli* BL21(DE3) strains expressing both *tesB* and *ptb-buk* (data not shown).

Discussion {#Sec14}
==========

Analysis of short-chain acyl-CoAs and adenosine phosphates in three sets of *E. coli* strains expressing clostridial genes for the biosynthesis of butyrate and butanol showed that *hbd* expression leads to observable 3HB-CoA pools only in Strain Set II, in which strong T7 promoters drive the expression of *hbd* (Tseng et al. [@CR20]). The P~LTetO1~-derived promoter and low-copy pSC101-derived plasmid used to express *hbd* in Strain Set \#1 did not result in detectable 3HB-CoA. ButCoA was not reliably detected in any of the strain sets, as indicated by the large relative uncertainties given in Table [2](#Tab2){ref-type="table"}.

The Δ~IPTG~ΔG′ for the conversion of AcCoA to 3HB-CoA was positive for all but one of the strains in Strain Set II, showing that induction of ketoacid reductase genes *phaB* or *hbd* tended to push the conversion of AcCoA to 3HB-CoA closer to equilibrium. The exception was strain \#11 (Table [1](#Tab1){ref-type="table"}), expressing the clostridial *hbd* gene for reduction of AcAcCoA to 3HB-CoA and the non-energy-conserving *tesB* gene for conversion of 3HB-CoA to free 3HB. In this strain Δ~IPTG~ΔG′ was negative, indicating that induction may have pushed the AcCoA to 3HB-CoA reaction further away from equilibrium. One possible explanation is that induction boosted the activity of TesB more than Hbd, thus draining away 3HB-CoA and indirectly disequilibrating the AcCoA to 3HB-CoA reaction.

A thermodynamic framework centered on the calculation of Δ~IPTG~ΔG′ revealed that the conversion of 3HB-CoA to ButCoA was not accelerated by induction of the *crt* or *bcd* enzymes, even under the oxygen-limiting conditions we studied. This finding is a confirmation of several other independent analyses that also pinpointed *bcd* as encoding the enzyme whose activity prevents *E. coli* from reaching its stoichiometric potential (Inui et al. [@CR11]; Nielsen et al. [@CR16]). One possibility is that very stoichiometry of the reaction catalyzed by the proteins coded by the *bcd/etfAB* genes has been misunderstood (Li et al. [@CR12]), at least in some species of *Clostridia*. Pool size measurements directly assess the performance of the individual steps of a recombinant pathway step under *in vivo* conditions, and are thus complementary to other techniques for dissecting the activity of recombinant pathways, such as enzyme assays or feeding studies, which usually involve physiological perturbations. We expect that combining pool size measurements with calculation of Δ~inducer~ΔG′ will be useful for the dissection and analysis of any metabolically engineered pathway whose performance is not yet satisfactory.
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